Altasciences Featured Articles

  1. CNS-Targeted Therapies Delivery Strategies And Sampling In Non-Rodent Preclinical Species 1/7/2025

    Ensure optimal tissue analysis and immune response management in preclinical models by using advanced delivery techniques and sampling methods.

  2. Germline Integration Assessment In Preclinical Gene Therapy Studies 1/7/2025

    Ensure the safety of gene therapy products by utilizing advanced preclinical methods and DNA isolation techniques to evaluate the potential for germline integration and minimize offspring risks.

  3. Safety Assessment For Ophthalmic Products 1/7/2025

    Plan your ocular drug development strategy with comprehensive preclinical studies to ensure regulatory success and smooth progression to first-in-human trials.

  4. Nonclinical Safety Testing Guide 1/7/2025

    Are you equipped with the tools you need to plan your preclinical studies? Check out this essential checklist to help plan your preclinical safety assessments.

  5. Key Considerations For Nonclinical AAV Gene Therapy Development 1/7/2025

    Looking to learn more on nonclinical AAV gene therapy development? Check out this essential eBook that will provide the latest insights on AAV gene therapy.

  6. A Changing Paradigm For Non-Rodent Species In Nonclinical Safety Studies 1/7/2025

    The choice of species for nonclinical safety studies is an important step in the drug development process. Check out this scientific journal which outlines vital considerations for species selection.

  7. Nonclinical Studies In CGT – Key Considerations And Regulatory Guidance 1/7/2025

    Looking for best practices and expert tips on how to address challenges and improve study efficiency in nonclinical gene therapy studies? Check out this scientific journal today!

  8. Considerations For Nonclinical Dermal Studies — Advancing To Phase 1 1/7/2025

    We encourage further exploration of dermal drug delivery approaches to enhance therapeutic development, leveraging specialized expertise and minipig models to successfully advance programs to Phase 1 clinical trials.

  9. Managing The Complexities Of Glucagon-Like Peptide-1 Receptor Agonist Drug Development 11/20/2024

    Dive into the dynamic world of GLP-1 receptor agonists, where we explore the current landscape, the challenges ahead and the complexities of early-phase drug development.

  10. Achieving Optimal Preclinical Formulation, Drug Product Manufacture 4/9/2024

    Developing and manufacturing drugs for preclinical testing marks a crucial initial phase preceding human trials. Delve into the essential considerations for preclinical formulation aimed at safety assessment.